Document is current
Any future updates will be listed below
-
Authors
Miller, Brendan F.
Pisanic II, Thomas R.
Margolin, Gennady
Petrykowska, Hanna M.
Athamanolap, Pornpat
Goncearenco, Alexander
Osei-Tutu, Akosua
Annunziata, Christina M.
Wang, Tza-Huei
Elnitski, Laura
-
Funding
Funding for this research was provided by:
National Human Genome Research Institute (Intramural Program)
National Cancer Institute (Intramural Program)
Sidney Kimmel Comprehensive Cancer Center (Johns Hopkins Kimmel Cancer Center-Allegheny Health Network)
National Institutes of Health (R01CA155305, R21CA186809, U54CA151838, U01CA214165)
Honorable Tina Brozman Foundation
- License Information
-
More Information
Article History
Received: 6 December 2019
Accepted: 21 September 2020
First Online: 20 October 2020
Ethics approval and consent to participate
: The study was conducted in accordance with the Declaration of Helsinki, was approved by the Institutional Review Board at the National Cancer Institute and registered with Clinicaltrials.gov (NCT01445509 and NCT00436215). All patients provided written informed consent at study enrollment.
: Not applicable.
: A preprint of this work has been deposited into the bioRxiv preprint server: ExternalRef removed.
: The authors declare that they have no competing interests.
